Trial site
Texas Oncology - Baylor Charles A. Sammons Cancer Center
- 34running trials
- 27closed trials
The trials here
What the 61 trials at this site are about, from their registry records.
- Conditions
- Lung cancer14 trials
- Colorectal cancer10 trials
- Metastatic breast cancer10 trials
- Melanoma7 trials
- Gastric and oesophageal cancer6 trials
- Head and neck cancer6 trials
- Ovarian cancer6 trials
- Endometrial cancer5 trials
- Pancreatic cancer5 trials
- Triple-negative breast cancer5 trials
- Kidney cancer4 trials
- Cervical cancer3 trials
- and 15 more
- Phase
- Phase 321 trials
- Phase 213 trials
- Phase 1/212 trials
- Phase 16 trials
- Phase 2/34 trials
- Status
- Active, not recruiting23 trials
- Completed17 trials
- Recruiting10 trials
- Terminated10 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Hoffmann-La Roche4 trials
- Pfizer4 trials
- Eli Lilly and Company3 trials
- BeOne Medicines2 trials
- BioNTech SE2 trials
- and 43 more
Running trials
Recruiting
Recruiting
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Enrolling by invitation
Active, not recruiting
Active, not recruiting
FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma
Recruiting
Recruiting
Recruiting
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Recruiting
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Cervical cancer2 recruiting
- Metastatic breast cancer2 recruiting
- Acute myeloid leukaemia1 recruiting
- Childhood cancers1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Lung cancer1 recruiting
- Neuroendocrine tumours1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Sickle cell disease1 recruiting
- Thalassaemia1 recruiting
Closed trials
Terminated
A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer
Completed
Terminated
Terminated
Terminated
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
Terminated
Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer
Completed
Completed
Completed
Terminated
Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Terminated
Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors
Completed
Completed
Terminated
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Completed
UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma
Completed
Terminated
Completed
Completed
Terminated
A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas
Completed
Completed
Completed
Completed
A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026